Evidence mapPaperPMID 33484617Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2021

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring.

Ji-Guang Wang, Yan Li, Yook-Chin Chia, Hao-Min Cheng, Huynh Van Minh, Saulat Siddique, Guru Prasad Sogunuru, Jam Chin Tay, Boon Wee Teo, Kelvin Tsoi and 5 more

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Telemedicine in the COVID-19 Era: A Narrative Review Based on Current Evidence.International journal of environmental research and public health · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 11 countries.

Ji-Guang WangCentre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, Department of Hypertension, Ruijin Hospital, The Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yan LiCentre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, Department of Hypertension, Ruijin Hospital, The Shanghai Institute of Hypertension, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-5825-5968
Yook-Chin ChiaDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0003-1995-0359
Hao-Min ChengInstitute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huynh Van MinhDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.ORCID 0000-0003-4273-4187
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.ORCID 0000-0003-1294-0430
Guru Prasad SogunuruMIOT International Hospital, Chennai, India.ORCID 0000-0002-1410-9328
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.ORCID 0000-0001-7657-4383
Boon Wee TeoDivision of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore.ORCID 0000-0002-4911-8507
Kelvin TsoiJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.ORCID 0000-0001-5580-7686
Yuda TuranaSchool of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.ORCID 0000-0003-4527-0285
Tzung-Dau WangCardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.ORCID 0000-0002-7180-3607
Yu-Qing ZhangDivisions of Hypertension and Heart Failure, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0001-8142-8305
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Hypertension Cardiovascular Outcome Prevention, Evidence (HOPE) Asia Network
Ruijin Hospital · CNAtma Jaya Catholic University of Indonesia · IDChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese University of Hong Kong · HKHue University · VNJichi Medical University · JPMadras Institute of Orthopaedics and Traumatology · INNational Taiwan University Hospital · TWNational Yang Ming Chiao Tung University · TWPunjab Medical Center · PKTan Tock Seng Hospital · SGUniversity of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of hypertension is high and still increasing in almost all communities regardless of high, middle, or low income. The control rate remains low in most countries. Telemedicine offers possibilities to improve blood pressure control. The past two decades witnessed the fast evolving telecommunication from telephone transmission to smart mobile phone technology for telemedicine. There is some evidence from randomized controlled trials that telemonitoring improves blood pressure control. However, it requires co-interventions. The emerging new technology may offer even more possibilities in telemonitoring and co-interventions, for instance, an interactive platform between patients and health professionals for the management of hypertension. Telemedicine might ultimately change the situation of the unsatisfactory management of hypertension in many communities. It helps fully utilize antihypertensive treatment, the most effective cardiovascular prevention, to achieve the goal of ending atherosclerosis and arteriosclerosis in humans.

Indexed as

HypertensionTelemedicineAntihypertensive AgentsBlood PressureBlood Pressure Monitoring, AmbulatoryHumansAntihypertensive Agentshypertensiontechnologytelemedicinetelemonitoring

Identifiers

PMID33484617
PMCPMC8029526
OpenAlexW3121912601

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.